Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES19 - Toxicity Avoidance in SABR for Early Stage NSCLC
- 12:15 - 13:15
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Stage Non-small Cell Lung Cancer - Radiotherapy and Other Ablative Techniques
- Moderators:Lizza Hendriks, Shankar Siva
-
+
ES19.06 - Chest Wall Myositis, Pleuritis and Rib Fracture
12:53 - 13:05 | Presenter: Maria Werner-Wasik
- Abstract
Loading...
-
+
MA14 - Palliative and Supportive Care - The Forgotten Trade
- 14:30 - 15:30
- 8/09/2022
- Location: Strauss 3
- Not for CME Credit
- Type: Mini Oral
- Track: Palliative and Supportive Care
- Moderators:Maria Werner-Wasik, Satoko Kono
-
+
Session Moderator
14:47 - 14:57 | Presenter: Maria Werner-Wasik
- Abstract
Loading... -
+
Session Moderator
14:47 - 14:57 | Presenter: Satoko Kono
- Abstract
Loading... -
+
MA14.01 - Session Introduction
14:30 - 14:31 | Presenter: Maria Werner-Wasik
- Abstract
Loading... -
+
MA14.02 - Session Introduction
14:31 - 14:32 | Presenter: Satoko Kono
- Abstract
Loading... -
+
MA14.03 - Effect of Mirtazapine on Energy Intake in Patients with Anorexia Associated with NSCLC
14:32 - 14:37 | Presenter: Oscar Arrieta
- Abstract
Loading... -
+
MA14.04 - Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study
14:37 - 14:42 | Presenter: Narjust Florez (Duma)
- Abstract
Loading... -
+
MA14.05 - A Double-blind Phase III Trial of Denosumab Biosimilar QL1206 vs Denosumab in Bone Metastatic Tumor: Lung Cancer Cohort Data
14:42 - 14:47 | Presenter: Yan Huang
- Abstract
Loading... -
+
MA14.06 - Discussant
14:47 - 14:57 | Presenter: Karin Dieckmann
- Abstract
Loading... -
+
MA14.07 - The Use of Medical Cannabis Concomitantly with Immune-Check Point Inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC): A Sigh of Relief?
14:57 - 15:02 | Presenter: Barliz Waissengrin
- Abstract
Loading... -
+
MA14.08 - Longitudinal Symptoms and Health Utility Scores (HUS) in Patients Receiving PD-1 Inhibitors for Metastatic NSCLC
15:02 - 15:07 | Presenter: Christopher Poletes
- Abstract
Loading... -
+
MA14.09 - Lower Paraspinous Muscle Index at First Thoracentesis is Associated with Poor Survival in Non-Small Cell Lung Cancer
15:07 - 15:12 | Presenter: Candice L. Wilshire
- Abstract
Loading... -
+
MA14.10 - Discussant
15:12 - 15:22 | Presenter: Devayani Niyogi
- Abstract
Loading... -
+
MA14.11 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
